Robert E. Guldberg is the Parker H. Petit Chair in Bioengineering and Bioscience. He is a Professor in the Georgia Institute of Technology's Woodruff School of Mechanical Engineering and Georgia Tech/Emory Department of Biomedical Engineering. Guldberg received all of his degrees from the University of Michigan in mechanical engineering and bioengineering and completed a post-doctoral fellowship in molecular biology. His research program is focused on musculoskeletal growth and development, regeneration of limb function following traumatic injury, and degenerative diseases such as skeletal fragility and osteoarthritis. Guldberg has advised 47 post-doctoral fellows and graduate students over the past 20 years and published over 180 peer-reviewed papers and book chapters. In 2009, Guldberg was appointed Executive Director of the Petit Institute for Bioengineering and Bioscience (IBB) (http://www.ibb.gatech.edu/). Under his leadership, the Petit Institute has grown to include over 175 faculty members from a broad range of science, engineering, and clinical disciplines, 17 interdisciplinary research centers, and three graduate programs in bioengineering, bioinformatics, and quantitative biosciences. Guldberg also co-directs the GT/Children’s Healthcare of Atlanta (CHOA) Center for Pediatric Innovation (CPI), co-chairs the Extremity Trauma Focus Area of the Armed Forces Institute for Regenerative Medicine (AFIRM) and is past co-director of the GT/Emory/UGA Center for Regenerative Engineering and Medicine (REM). Guldberg serves on numerous advisory and editorial boards and has held several national leadership positions, including most recently President of the Americas Chapter of the Tissue Engineering and Regenerative Medicine International Society (TERMIS-AM). He is a CHOA research scholar and has been elected a Fellow of both TERMIS and the American Institute for Medical and Biological Engineering (AIMBE).
Bob Guldberg's research interests focus on musculoskeletal growth and development, functional regeneration following traumatic injury, and degenerative diseases, including skeletal fragility and osteoarthritis. His research is supported by the NIH, NSF, DoD, and several biotechnology companies and has resulted in over 150 book chapters and publications. Guldberg is a Fellow of the American Institute for Medical and Biological Engineering (AIMBE) and holds several national leadership positions.